Good At

Specializing in the clinical and precise diagnosis, drug therapy, gene therapy, stem cell therapy and genetic risk assessment of various complex congenital and hereditary eye diseases, as well as systemic syndromes with eye lesions, such as retinitis pigmentosa, congenital static night blindness, crystalline retinitis pigmentosa, congenital amaurosis, macular degeneration, rod malnutrition, Best disease, congenital retinoschisis, congenital agoradiosis, optic neuropathy, color blindness, microphthalmia, Congenital nystagmus, pathological myopia, congenital cataracts, congenital glaucoma and corneal degeneration.

Introduction

Ophthalmologist, researcher, doctoral supervisor, leading talent in Shanghai, outstanding academic leader in Shanghai City, and leading medical talent in Shanghai City. He is currently the deputy director of ophthalmology at the Eye, Otorhinolaryngology Hospital Affiliated to Fudan University, the executive vice president of the Academy of Ophthalmology, the director of the Center for Precise Diagnosis and Treatment of Genetic Eye Diseases, the deputy chairman of the Ophthalmology and Visual Science Special Committee of China Research Hospital, and the Shanghai City Key Laboratory for Visual Damage and Reconstruction. Deputy director of the laboratory, committed to the precise diagnosis, gene therapy, drug therapy, stem cell therapy, and next-generation genetic risk assessment of ocular genetic diseases. He has gone to the National Institutes of Health NEI many times to study the precise diagnosis and treatment of genetic eye diseases. He has taken the lead in establishing a genetic eye disease specialist in China and has accumulated rich experience in diagnosis and treatment. He has presided over nearly 20 projects at or above the provincial and ministerial levels, including key R & D plan projects of the Ministry of Science and Technology, general projects of the National Natural Fund of China, and major special projects of the Shanghai City Science and Technology Commission. In recent years, he has published more than 150 SCI papers, with 15 IF>10 points. Authorize 7 national invention patents. The achievement won the first prize in the Shanghai City Science and Technology Progress Award.